Reply to: Correspondence on "EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update"

被引:2
|
作者
Berzigotti, Annalisa
Tsochatzis, Emmanouil
Boursier, Jerome
Castera, Laurent
Cazzagon, Nora
Friedrich-Rust, Mireen
Petta, Salvatore
Thiele, Maja
机构
关键词
RISK;
D O I
10.1016/j.jhep.2021.10.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:251 / 252
页数:2
相关论文
共 50 条
  • [21] Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
    Musso, Giovanni
    Gambino, Roberto
    Cassader, Maurizio
    Pagano, Gianfranco
    ANNALS OF MEDICINE, 2011, 43 (08) : 617 - 649
  • [22] Early evaluation of liver disease severity with non-invasive tests in the era of new direct acting antiviral drugs (DAAs): a pilot study.
    Stradella, Davide
    Gaia, Silvia
    Vanni, Ester
    Rolle, Emanuela
    Campion, Daniela
    Cortegoso, Pablo
    Evangelista, Andrea
    Ciancio, Alessia
    Smedile, Antonina
    Saracco, Giorgio Maria
    HEPATOLOGY, 2016, 64 : 328A - 328A
  • [23] EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?
    Byrne, Christopher D.
    Targher, Giovanni
    DIABETOLOGIA, 2016, 59 (06) : 1141 - 1144
  • [24] Suitability of non-invasive tests in the evaluation of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
    Yague Parada, Alvaro
    Castaneda Agredo, Andres Felipe
    Calvo Hernandez, Rocio
    Gonzalez Guirado, Agustina
    Varela Silva, Andres
    Moran Ortiz de Solorzano, Marta
    Casanova Cabral, Michelle
    Polo Lorduy, Benjamin
    JOURNAL OF HEPATOLOGY, 2024, 80 : S598 - S598
  • [25] Performance of non-invasive methods in the assessment of disease severity in routine clinical practice in patients with chronic hepatitis C
    Martinez, Stella M.
    Dominguez, Marlene
    Fernandez-Varo, Guillermo
    Gonzalez, Patricia
    Bataller, Romon
    Sampson, Ellen
    Jimenez, Wladimiro
    Forns, Xavier
    Sanchez-Tapias, Jose M.
    HEPATOLOGY, 2007, 46 (04) : 318A - 319A
  • [26] Reply to: Non-invasive tests and advanced chronic liver disease in NAFLD: two steps forward and one step back?
    Pavlides, Michael
    Mozes, Ferenc E.
    Harrison, Stephen A.
    GUT, 2022, 71 (07) : 1453 - 1454
  • [27] Long-term non-invasive ventilation in patients with chronic obstructive pulmonary disease (COPD): 2021 Canadian Thoracic Society Clinical Practice Guideline update
    Kaminska, Marta
    Rimmer, Karen P.
    McKim, Douglas A.
    Nonoyama, Mika
    Giannouli, Eleni
    Morrison, Debra L.
    O'Connell, Colleen
    Petrof, Basil J.
    Maltais, Francois
    CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2021, 5 (03) : 160 - 183
  • [28] Validation of serum non-invasive tests of liver fibrosis as prognostic markers of clinical outcomes in people with fatty liver disease in Australia
    Vaz, Karl
    Kemp, William
    Majeed, Ammar
    Lubel, John
    Magliano, Dianna J.
    Glenister, Kristen M.
    Bourke, Lisa
    Simmons, David
    Roberts, Stuart K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2025, 40 (01) : 241 - 249
  • [29] IMPACT OF BMI ON NIS2+TM AND ESTABLISHED NON-INVASIVE TESTS FOR THE EVALUATION OF NON-ALCOHOLIC LIVER DISEASE
    Francque, Sven
    Harrison, Stephen A.
    Schattenberg, Jorn
    Alard, Berenice
    Magnanensi, Jeremy
    Majd, Zouher
    Hum, Dean W.
    Staels, Bart
    Anstee, Quentin M.
    Ratziu, Vlad
    Sanyal, Arun
    HEPATOLOGY, 2023, 78 : S246 - S249
  • [30] Non-invasive tests for assessing fibrosis in patients with non-alcoholic fatty liver disease: an evaluation of combining test results
    Vick, Catherine
    Joyce, Andrew
    Law, Amy
    Sherwood, Molly
    Mozaffari, Essy
    Wong, Bruce
    JOURNAL OF HEPATOLOGY, 2020, 73 : S404 - S404